SWOG clinical trial number
S0340

A Prospective Observational Study of Patients with Solitary Plasmacytoma Using a Modified Staging System Supplemented by an MRI and Whole Body FDG-PET Scan

2% Accrual
Accrual
2%
Closed
Phase
2% Accrual
Accrual
2%
Abbreviated Title
Solitary Plasmacytoma
Activated
04/15/2005
Closed
02/15/2007
Participants
NCORP, Members, Medical Oncologists, Radiation Oncologists, Pathologists

Research committees

Myeloma